Search

Your search keyword '"Antiviral agents -- Product introduction"' showing total 12 results
Start Over Descriptor "Antiviral agents -- Product introduction" Topic business, international
12 results on '"Antiviral agents -- Product introduction"'

1. United States : Trump EPA Approves First-Ever Long-Lasting Antiviral Product for Use Against COVID-19

Subjects
United States. Environmental Protection Agency, American Airlines Inc. -- Product introduction, Coronaviruses -- Health aspects, Antiviral agents -- Product introduction, Government agencies -- Health aspects, COVID-19 -- Health aspects, Business, international
Abstract

U.S. Environmental Protection Agency (EPA) Administrator Andrew Wheeler announced a groundbreaking development in the Trump Administrations efforts to combat the novel coronavirus. In a first-of-its kind step, EPA has issued [...]

Published
2020

2. 10x Genomics Launches Next Generation Immune Profiling Product to Combat COVID-19

Subjects
Vaccines -- Product introduction, Antiviral agents -- Product introduction, Autoimmunity, COVID-19, Business, international, Law
Abstract

(GlobeNewswire) - 10x Genomics(Nasdaq: TXG) strengthened the research toolkit of scientists around the globe today with the launch of its Chromium Single Cell Immune Profiling v2 product. The new product [...]

Published
2020

3. New product information wording - Extracts from PRAC recommendations on signals Adopted at the 1-4 October 2018 PRAC

Subjects
Glecaprevir -- Product introduction, Pibrentasvir -- Product introduction, Norelgestromin, Dienogest, Antiviral agents -- Product introduction, Conjugated estrogens -- Product introduction, Dolutegravir, Etonogestrel, Teriflunomide, Voxilaprevir -- Product introduction, Protease inhibitors -- Product introduction, Drospirenone -- Product introduction, Risk assessment, Web sites (World Wide Web), Business, international
Abstract

Amsterdam: European Medicines Agency has issued the following document: 30 Churchill Place * Canary Wharf * London E14 5EU * United Kingdom An agency of the European Union Telephone +44 [...]

Published
2019

4. From antivirals to Viagra: drug review of '98

Subjects
Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Antibacterial agents -- Product introduction, Cardiovascular agents -- Product introduction, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries
Published
1999

5. Banishing bacteria

Author

Cozier, Muriel

Subjects
Perstorp AB -- Product introduction, Anti-infective agents -- Product introduction, Antiviral agents -- Product introduction, Chemical industry -- Product introduction, Herbicides -- Product introduction, Pesticides industry -- Product introduction, Business, Business, international, Chemicals, plastics and rubber industries
Abstract

Perstorp has introduced a series of antiviral and anti-microbial moulding compounds. Polygiene can be used to make a number of products including sanitaryware, handles, pens and public phones. The company [...]

Published
2004

6. Gilead Sciences. (UK Drug Update)

Subjects
Gilead Sciences Inc. -- Product introduction, Biological products industry -- Product introduction, Antiviral agents -- Product introduction, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries, Hepsera (Medication) -- Product introduction
Published
2003

7. Roche Products. (UK Drug Update)

Subjects
Roche Products Ltd. -- Product introduction, Influenza -- Drug therapy, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries, Tamiflu (Medication) -- Product introduction
Published
2003

8. Therapeutics

Subjects
Antiviral agents -- Product introduction, Analgesics -- Product introduction, Prostaglandins -- Usage, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries
Published
1992

9. Agouron girds to join AIDS-drug battle: biotech firm's Viracept is a pricey late entry

Author

Rundle, Rhonda L.

Subjects
Agouron Pharmaceuticals Inc. -- Product introduction -- 00211436, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, AIDS (Disease) -- Drug therapy, Banking, finance and accounting industries, Business, Business, international, Viracept (Medication) -- Product introduction
Published
1997

10. Schering - pinning its hopes on MS drug

Subjects
Bayer HealthCare Pharmaceuticals -- Product introduction, Antiviral agents -- Product introduction, Multiple sclerosis -- Care and treatment, Business, Business, international, Pharmaceuticals and cosmetics industries
Abstract

Schering expects 20 million US dollar sales in 1993 from Betaseron, a beta interferon targeted at the treatment of relapsing-remitting multiple sclerosis (MS). For 1994, sales of 200 million US dollars are forecast. The product received FDA approval in July 1993, and it hit the US market in October of the same year. The company plans to invest 860 million Deutsche Marks (DM) in 1994 on R&D, compared to DM800 million in 1993.

Published
1993

11. Hepatitis A vaccine - licence potential?

Subjects
Pasteur Merieux Serums et Vaccins S.A. -- Product introduction, Pharmaceutical industry -- Product introduction, Hepatitis A -- Drug therapy, Vaccines -- Product introduction, Antiviral agents -- Product introduction, Business, Business, international, Pharmaceuticals and cosmetics industries, Avaxim (Medication) -- Product introduction
Abstract

Pharmaceutical joint venture Pasteur Merieux has launched its Avaxin hepatitis A vaccine in the U.K.. The company had been expected to introduce Vaqta, which has received licenses in the U.S. and Germany. Pasteur Merieux's director of business relations says that the two vaccines are very similar.

Published
1996

12. Wellcome launches successor to ageing blockbuster Zovirax

Subjects
Wellcome PLC -- Product introduction, Antiviral agents -- Product introduction, Business, Business, international, Pharmaceuticals and cosmetics industries
Abstract

Wellcome UK has introduced Valtrex, a new antiviral drug and a development of its Zovirax antiviral agent. Valtrex will treat herpes zoster and the company hopes the drug will help it maintain its major share of the antiviral. Valtrex is said to resolve acute shingles pain faster than Zovirax and it has improved bioavailability.

Published
1995

Catalog

Books, media, physical & digital resources
See catalog results